The curriculum provides a comprehensive understanding of:

• Health outcomes, including clinical effectiveness, safety, cost, and patient-reported outcomes
• Unique value propositions relevant to payers, providers and regulators
• Data storytelling and visualization to differentiate a pharmaceutical product or service
• Communication tools such as value slide decks, formulary dossiers, abstracts, posters, and manuscripts that are compliant with regulations
• Evidence synthesis through systematic reviews and meta-analyses
• Levels of evidence, including randomized controlled trials, meta-analyses, prospective and retrospective observational studies, and economic modeling
• Types of evidence derived at various phases of drug development and commercialization, from early discovery to post-approval market access

Credit hours:

• Grad certificate:  16 credits.  Tuition: 16 x $750 = $12,000
• UF M.S. degree:  32 credits.  32 x $750 = $24,000
• M.S.+MBA program:  52 credits (26 UF + 26 Stetson).  Tuition:  UF (26 x $750) + Stetson (26 x $1,050) =  $46,800UF M.S. degree portion:  32 credits (26 UF credits + 6 Stetson transfer credits)
• Stetson M.B.A. degree portion:  36 credits (26 Stetson credits + 9 UF transfer credits)